Prosecution Insights
Last updated: April 19, 2026

Westlake Therapeutics (Hangzhou) Co. Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18251030 Modified Red Blood Cells and Uses Thereof for Delivering Agents JACKSON III, WALTER 1638 Non-Final OA Apr 28, 2023
17906435 Modified Red Blood Cells and Uses Thereof for Delivering Agents STEADMAN, DAVID J 1656 Non-Final OA Sep 15, 2022

Managing Westlake Therapeutics (Hangzhou) Co. Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month